Navigation Links
Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?

Erectile dysfunction (ED) is the inability of a man to achieve or maintain an erection sufficient for his sexual needs or the needs of his partner. Most men experience this at some point in their lives//, usually by age 40, and are not psychologically affected by it. Some men, however, experience chronic, complete ED (impotence), and often leads to diminished self-esteem.

According to a new study in the October 18 issue of the Journal of the American College of Cardiology, erectile dysfunction can represent an early clinical manifestation of a diffuse subclinical vascular disease and coronary artery disease is the most important problem that needs to be investigated. The smaller penile arteries suffer obstruction from plaque burden earlier than the larger coronary arteries hence ED may be symptomatic before a coronary event.

The purpose of the study, conducted in the University of Modena and Reggio Emilia, Modena, Italy, was to assess the prevalence and extent of coronary artery atherosclerosis in asymptomatic patients with vascular ED.

The researchers studied 70 patients with vascular ED, and 73 control subjects with no history of coronary artery disease. They measured traditional coronary risk factors, circulating levels of C-reactive protein (CRP), endothelial function by ultrasound of brachial artery, and coronary artery calcification by multi-slice computed tomography. The patients and the control group were similar for age, race, and coronary risk score.

The men with ED had significantly higher levels of C-reactive protein (an emerging coronary risk factor), they were more likely to have abnormal blood vessel responses to changes in blood flow (as measured by flow mediated dilation), and more of them had coronary artery calcifications detected on coronary CT scans.

The results of this study indicate that coronary atherosclerosis was found to be more severe in patients with vascular ED; ED predicts the presence a nd extent of subclinical atherosclerosis independent of traditional risk factors for cardiovascular disease. Thus, ED may be considered an additional, early warning sign of coronary atherosclerosis.

Despite the limitations of the study, it is perceived that the findings indicate erectile dysfunction should be treated as a possible signal of the early stages of atherosclerosis.
'"/>




Related medicine news :

1. Erectile dysfunction (ED) signals vascular disease
2. An Exploration into Erectile Dysfunction in Diabetics
3. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
4. Cardiovascular Disease More Common Among Erectile Dysfunction Patients
5. Erectile Dysfunction Connected To Heart Disease
6. Statins For Erectile Dysfunction- An Alternative To Viagra?
7. Erectile Dysfunction Can Be Rectified By Healthy Way Of Life
8. Host of Benefits from Erectile Dysfunction Drugs
9. Erectile Dysfunction Linked with Smoking and Obesity – Study Report
10. South Africans Turn to Natural Remedies for Treating Erectile Dysfunction
11. HIV and Erectile Medications - No Link Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert ... Core benefits and advantages built into the home office sit stand solution are ... feel. Ability to gain the benefits embedded in the TaskMate Go are available ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. Hawkins, vice ... appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new ... 10. Dr. Bell comes to Liberty from the Ohio University Heritage College of ...
(Date:2/24/2017)... ... ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” (published by ... Schanssema describes the tragedies he saw, as well as his struggles with grief and ... unsure of the career path he wanted to take, found fulfillment in a career ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced ... the Chairman of the Management Committee when IFN was originally formed in 2002 where ... investor/owners and development of the business plan. He became the first paid employee ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
Breaking Medicine Technology: